Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

[Influence of preoperative chemoradiotherapy on pulmonary function and postoperative pulmonary complication in esophageal cancer patients].

Hu RG, Fu JH, Luo KJ, Zhang X, Yang H, Liu MZ, Liu H, Li Q, Hu YH, Li XD, Lin T.

Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Sep;16(9):827-30. Chinese.

PMID:
24061986
2.
3.

[Postoperative respiratory failure in patients with cancer of esophagus and gastric cardia].

Mao YS, Zhang DC, He J, Zhang RG, Cheng GY, Sun KL, Wang LJ, Yang L.

Zhonghua Zhong Liu Za Zhi. 2005 Dec;27(12):753-6. Chinese.

PMID:
16483491
4.

Preoperative chemoradiotherapy for esophageal cancer: factors associated with clinical response and postoperative complications.

Morita M, Masuda T, Okada S, Yoshinaga K, Saeki H, Tokunaga E, Endo K, Emi Y, Kakeji Y, Maehara Y.

Anticancer Res. 2009 Jul;29(7):2555-62.

5.

Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters.

Lee HK, Vaporciyan AA, Cox JD, Tucker SL, Putnam JB Jr, Ajani JA, Liao Z, Swisher SG, Roth JA, Smythe WR, Walsh GL, Mohan R, Liu HH, Mooring D, Komaki R.

Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1317-22.

PMID:
14630268
6.

High-dose preoperative chemoradiotherapy in esophageal cancer patients does not increase postoperative pulmonary complications: correlation with dose-volume histogram parameters.

Hurmuzlu M, Øvrebø K, Wentzel-Larsen T, Muren LP, Viste A, Smaaland R.

Radiother Oncol. 2010 Oct;97(1):60-4. doi: 10.1016/j.radonc.2010.06.008. Epub 2010 Aug 11.

PMID:
20708284
7.

Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.

Tucker SL, Liu HH, Wang S, Wei X, Liao Z, Komaki R, Cox JD, Mohan R.

Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):754-61. Epub 2006 Sep 11.

PMID:
16965865
8.

Preoperative chemoradiotherapy for esophageal cancer enhances the postoperative systemic inflammatory response.

Tsujimoto H, Ono S, Chochi K, Sugasawa H, Ichikura T, Mochizuki H.

Jpn J Clin Oncol. 2006 Oct;36(10):632-7. Epub 2006 Oct 4.

PMID:
17020895
9.

[Influence of perioperative hypertension on postoperative cardiovascular complications in chest cancer patients].

Wang YN, Long H, Lin P, Lin YB, Lin ZC, Si-Tu DR, Ma G, Huang ZF, Rong TH.

Ai Zheng. 2007 May;26(5):537-40. Chinese.

PMID:
17672948
10.

Influence of irradiated lung volumes on perioperative morbidity and mortality in patients after neoadjuvant radiochemotherapy for esophageal cancer.

Dähn D, Martell J, Vorwerk H, Hess CF, Becker H, Jung K, Hilgers R, Wolff HA, Hermann RM, Christiansen H.

Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):44-52. doi: 10.1016/j.ijrobp.2009.04.053. Epub 2009 Aug 11.

PMID:
19679407
11.

The role of preoperative pulmonary function tests in the surgical treatment of scoliosis.

Zhang JG, Wang W, Qiu GX, Wang YP, Weng XS, Xu HG.

Spine (Phila Pa 1976). 2005 Jan 15;30(2):218-21.

PMID:
15644760
12.

[Lung scintigraphy and ergospirometry in prediction of postoperative course in lung resection candidates with increased risk of postoperative complications].

Bolliger CT, Wyser C, Roser H, Stulz P, Solèr M, Perruchoud AP.

Pneumologie. 1996 May;50(5):334-41. German.

PMID:
8710817
13.

Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.

Miyoshi N, Yano M, Takachi K, Kishi K, Noura S, Eguchi H, Yamada T, Miyashiro I, Ohue M, Ohigashi H, Sasaki Y, Ishikawa O, Doki Y, Imaoka S.

J Surg Oncol. 2009 Apr 1;99(5):302-6. doi: 10.1002/jso.21235.

PMID:
19170110
14.

Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?

Leo F, Solli P, Spaggiari L, Veronesi G, de Braud F, Leon ME, Pastorino U.

Ann Thorac Surg. 2004 Jan;77(1):260-5; discussion 265.

PMID:
14726074
15.

Chemoradiotherapy with and without esophagectomy for advanced esophageal cancer.

Nakamura T, Ota M, Hayashi K, Eguchi R, Ide H, Takasaki K, Mitsuhashi N.

Hepatogastroenterology. 2006 Sep-Oct;53(71):705-9.

PMID:
17086873
16.

Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity.

Rice DC, Correa AM, Vaporciyan AA, Sodhi N, Smythe WR, Swisher SG, Walsh GL, Putnam JB Jr, Komaki R, Ajani JA, Roth JA.

Ann Thorac Surg. 2005 Feb;79(2):391-7; discussionn 391-7.

PMID:
15680801
17.

[Influence of pulmonary function after combined thoracoscopic and laparoscopic esophagectomy for the treatment of esophageal carcinoma].

Chen BF, Kong M, Zhu CC, Ye ZR, Ye MH, Chen CY, Jia LM, Zhang B, Ye JH.

Zhonghua Wai Ke Za Zhi. 2012 Jul;50(7):633-6. Chinese.

PMID:
22943996
18.

Airway colonisation and postoperative pulmonary complications after neoadjuvant therapy for oesophageal cancer.

D'Journo XB, Michelet P, Papazian L, Reynaud-Gaubert M, Doddoli C, Giudicelli R, Fuentes PA, Thomas PA.

Eur J Cardiothorac Surg. 2008 Mar;33(3):444-50. doi: 10.1016/j.ejcts.2007.09.046. Epub 2008 Jan 14.

PMID:
18249002
19.

Surgical treatment for pulmonary metastases from esophageal carcinoma after definitive chemoradiotherapy: experience from a single institution.

Kozu Y, Sato H, Tsubosa Y, Ogawa H, Yasui H, Kondo H.

J Cardiothorac Surg. 2011 Oct 12;6:135. doi: 10.1186/1749-8090-6-135.

20.

Preoperative versus postoperative chemoradiotherapy in the trimodality management of esophageal cancer.

Kim C, Monjazeb AM, Suntharalingam M, Giesinger KR, Blackstock AW.

Clin Adv Hematol Oncol. 2009 May;7(5):327-333, 342. Review.

PMID:
19521322

Supplemental Content

Support Center